Rainbow Clinical Research Network is categorized under Medical Research in Columbia, MD and active since 2000.
Rainbow Clinical Research Network was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Donna Smith at the company’s single location by writing to 9017 Red Branch Road, Columbia, Maryland MD 21045 or by phoning (410) 997-5599. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rainbow Clinical Research Network |
| Contact Person: | Donna Smith |
| Address: | 9017 Red Branch Road, Columbia, Maryland 21045 |
| Phone Number: | (410) 997-5599 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Rainbow Clinical Research Network was started in 2000 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Donna Smith for inquiries that concern Rainbow Clinical Research Network by calling the company number (410) 997-5599, as your correspondence is most welcome. Additionally, the physical location of the single location of Rainbow Clinical Research Network can be found at the coordinates 39.22752,-76.819818 as well as the street address 9017 Red Branch Road in Columbia, Maryland 21045.
For its online presence, you may visit Rainbow Clinical Research Network’s website at and engage with its social media outlets through on Twitter and on Facebook.